שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - nadroparinum calcicum - soluzione iniettabile - nadroparinum calcicum ca. 25 mg corresp. 2850 u.i., aqua ad iniectabile q.s. ad solutionem pro 0.3 ml. - anticoagulante - biotechnologika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - nadroparinum calcicum - soluzione iniettabile - nadroparinum calcicum ca. 50 mg corresp. 5700 u.i., aqua ad iniectabile q.s. ad solutionem pro 0.6 ml. - anticoagulante - biotechnologika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - nadroparinum calcicum - soluzione iniettabile - nadroparinum calcicum ca. 17 mg corresp. 1900 u.i., aqua ad iniectabile q.s. ad solutionem pro 0.2 ml. - anticoagulante - biotechnologika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - nadroparinum calcicum - soluzione iniettabile - nadroparinum calcicum ca. 33 mg corresp. 3800 u.i., aqua ad iniectabile q.s. ad solutionem pro 0.4 ml. - anticoagulante - biotechnologika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - nadroparinum calcicum - soluzione iniettabile - nadroparinum calcicum ca. 67 mg corresp. 7600 u.i., aqua ad iniectabile q.s. ad solutionem pro 0.8 ml. - anticoagulante - biotechnologika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - nadroparinum calcicum - soluzione iniettabile - nadroparinum calcicum ca. 83 mg corresp. 9500 u.i., aqua ad iniectabile q.s. ad solutionem pro 1 ml. - anticoagulante - biotechnologika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in siringhe preriempite - interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.06 mg. - multiple sklerose - biotechnologika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in siringhe preriempite - interferonum beta-1a adnr 44 µg corresp. 12 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.1 mg. - multiple sklerose - biotechnologika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in siringhe preriempite - interferonum beta-1a adnr 8.8 µg corresp. 2.4 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.02 mg. - multiple sklerose - biotechnologika

שווייץ - איטלקית - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - soluzione iniettabile in siringhe preriempite - i) 8.8 mcg/0.2 ml: interferonum beta-1a adnr 8.8 µg corresp. 2.4 mio u.i., alcohol benzylicus 1.0 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.01 mg. ii) 22 mcg/0.5 ml: interferonum beta-1a adnr 22 µg corresp. 6 mio u.i., alcohol benzylicus 2.5 mg, mannitolum, methioninum, poloxamerum 188, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium max. 0.03 mg. - multiple sklerose - biotechnologika